2010 Scrip 100 - The flu pandemic: mild at first, but could turn nasty
09 December 2009
Ian Schofield
Please Login to read the full article.
09 December 2009
Ian Schofield
The swine flu pandemic shook up national governments and their populations in 2009, but H1N1 proved to be a boon for manufacturers of antiviral products, notably Roche and GlaxoSmithKline. Meanwhile, other companies are planning new kinds of vaccines to cope with future flu outbreaks, reports...
Please Login to read the full article.
RELATED CONTENT
NEWS
- BARDA bestows $215 million flu vaccine contract on Novavax, VaxInnate
- BARDA rescues BioCryst with additional $55 million for peramivir
- US Capitol Capsule: Will sequestration be a better outcome for biopharma?
- US Capitol Capsule: With wish granted, Collins forges ahead with new translational science centre
COMMENT
Other Informa Comment
FEATURES
Other Informa Features
EVENTS
26 February 2012
Vancouver Convention Centre | Vancouver, BC, Canada
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
JOB OF THE WEEK
Promote your vacancy here
